Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer.
Polee, M B
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. [electronic resource] - British journal of cancer Mar 2002 - 669-73 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
0007-0920
10.1038/sj.bjc.6600166 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Cisplatin--administration & dosage
Disease Progression
Drug Administration Schedule
Esophageal Neoplasms--drug therapy
Esophagogastric Junction--pathology
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Nervous System--drug effects
Neutropenia--chemically induced
Paclitaxel--administration & dosage
Survival Analysis
Treatment Outcome
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. [electronic resource] - British journal of cancer Mar 2002 - 669-73 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
0007-0920
10.1038/sj.bjc.6600166 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Cisplatin--administration & dosage
Disease Progression
Drug Administration Schedule
Esophageal Neoplasms--drug therapy
Esophagogastric Junction--pathology
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Nervous System--drug effects
Neutropenia--chemically induced
Paclitaxel--administration & dosage
Survival Analysis
Treatment Outcome